-
.
Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
2025.
-
代娇娇.
Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,
281,
2025.
-
黄伯世.
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies.
Journal of Medicianal Chemistry,
64,
13604-13621,
2023.
-
黄伯世.
First discovery of a potential carbonate prodrug of NNRTI drug candidate RDEA427 with submicromolar inhibitory activity against HIV-1 K103N/Y181C double mutant strain.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS,
28,
1348,
2023.
-
Design of bivalent ligands targeting putative GPCR dimers.
Drug Discovery Today,
26,
189-199,
2022.